Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bachmann

Showing results (141-150 of 577) with videos related to

Pageof 58
Sort By:
The Journal of Clinical Investigation|December 1, 1984
Tissue-type plasminogen activator increases the binding of glu-plasminogen to clotsC Tran-Thang, E K Kruithof, F Bachmann
Journal of the European Academy of Dermatology and Venereology : JEADV|April 27, 2011
Consecutively injected fillers in the same region do not pose an increased risk for adverse reactionsF Bachmann, R Erdmann, V Hartmann, et al.
Pneumologie (Stuttgart, Germany)|September 30, 2016
[Sporadic Lymphangioleiomyomatosis (sLAM) and Tuberous Sclerosis Complex (TSC) - Pulmonary Manifestations]S Brakemeier, C Grohé, F Bachmann, et al.
Expert Opinion on Biological Therapy|December 12, 2018
A vaccine against Alzheimer`s disease: anything left but faith?Martin F Bachmann, Gary T Jennings, Monique Vogel
Current Opinion in Clinical Nutrition and Metabolic Care|November 27, 2025
Core outcome sets and trials of nutrition and metabolism interventionsAnnika Reintam Blaser, Thomas Davies, Kaspar F Bachmann
Immunological Reviews|May 31, 2020
The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics"Mona O Mohsen, Gilles Augusto, Martin F Bachmann
Drug Discovery Today|October 24, 2006
A second vaccine revolution for the new epidemics of the 21st centuryMark R Dyer, Wolfgang A Renner, Martin F Bachmann
International Archives of Allergy and Immunology|June 17, 2020
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and InfectionHans-Uwe Simon, Alexander V Karaulov, Martin F Bachmann
European Radiology|April 7, 2004
MR imaging of compartment syndrome of the lower leg: a case control studyM B Rominger, C J Lukosch, G F Bachmann
Molecular Immunology|May 14, 2004
Enhanced apoptotic activity of a structurally optimized form of galectin-1Patrick Bättig, Philippe Saudan, Tea Gunde, et al.
Pageof 58

Showing results (141-150 of 577) with videos related to

Sort By:
Pageof 58
The Journal of Clinical Investigation|December 1, 1984
Tissue-type plasminogen activator increases the binding of glu-plasminogen to clotsC Tran-Thang, E K Kruithof, F Bachmann
Journal of the European Academy of Dermatology and Venereology : JEADV|April 27, 2011
Consecutively injected fillers in the same region do not pose an increased risk for adverse reactionsF Bachmann, R Erdmann, V Hartmann, et al.
Pneumologie (Stuttgart, Germany)|September 30, 2016
[Sporadic Lymphangioleiomyomatosis (sLAM) and Tuberous Sclerosis Complex (TSC) - Pulmonary Manifestations]S Brakemeier, C Grohé, F Bachmann, et al.
Expert Opinion on Biological Therapy|December 12, 2018
A vaccine against Alzheimer`s disease: anything left but faith?Martin F Bachmann, Gary T Jennings, Monique Vogel
Current Opinion in Clinical Nutrition and Metabolic Care|November 27, 2025
Core outcome sets and trials of nutrition and metabolism interventionsAnnika Reintam Blaser, Thomas Davies, Kaspar F Bachmann
Immunological Reviews|May 31, 2020
The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics"Mona O Mohsen, Gilles Augusto, Martin F Bachmann
Drug Discovery Today|October 24, 2006
A second vaccine revolution for the new epidemics of the 21st centuryMark R Dyer, Wolfgang A Renner, Martin F Bachmann
International Archives of Allergy and Immunology|June 17, 2020
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and InfectionHans-Uwe Simon, Alexander V Karaulov, Martin F Bachmann
European Radiology|April 7, 2004
MR imaging of compartment syndrome of the lower leg: a case control studyM B Rominger, C J Lukosch, G F Bachmann
Molecular Immunology|May 14, 2004
Enhanced apoptotic activity of a structurally optimized form of galectin-1Patrick Bättig, Philippe Saudan, Tea Gunde, et al.
Pageof 58